| 2010 - |
Head of Department |
Department of Biology |
| 2004 - |
Professor |
Department of Biology, Centre for Immunology and Infection, University of York/Hull York Medical School |
| 1999 - 2004 |
Professor |
Department of Biochemistry, Imperial College London |
| 1984 - 1999 |
Lecturer/Senior Lecturer/Reader |
Department of Biochemistry, Imperial College London |
| 1976 - 1983 |
Post-doc |
National Institute for Medical Research, UK; NCI-NIH, USA; Imperial College London |
| 1976 |
PhD |
University of Southampton |
| 1973 |
BSc |
University of Southampton |
Parasitic protozoa give rise to some of the most widespread human diseases. Our research focuses mainly on the Leishmaniases, caused by species of the kinetoplastid parasite, Leishmania, that live intracellularly in cells of the immune system. Our long-term aims are to understand host/parasite interactions and to develop novel drugs and vaccines. Current projects focus on the functional analyses of infective-stage Leishmania proteins; comparative genomic analysis of Leishmania species that cause different disease tropisms; structure/function studies on N-myristoyl transferase and its downstream targets in Leishmania, Trypanosoma Drucei and the malaria parasite, Plasmodium falciparum.
Discoveries
We were part of the international consortium that sequenced Leishmania species responsible for different types of clinical disease and collaborate with the Sanger Institute and international colleagues to exploit genomic approaches in Leishmania biology. We functionally analysed an essential downstream target of N-myristoyl transferase (NMT) in African trypanosomes and used this information to validate specific enzyme inhibitors in vivo. With colleagues, we identified lead compounds for the development of specific inhibitors of Plasmodium falciparum NMT. These advances have supported development of an integrated translational research project to screen NMT from three parasite species for new small molecule inhibitors suitable for pre-clinical drug development.
Most recently, we have identified proteins that are essential for Leishmania development in its sand fly vector and are currently investigating the molecular mechanisms involved in this process.
| Status | Name |
Project |
|---|---|---|
| Post doctoral fellow | Helen P Price |
Functional analysis of downstream targets of N-myristoyl transferase in
trypanosomes and Leishmania |
| Post doctoral fellow | Lorna Maclean | Human African Trypanosomiasis; development of an in vitro blood brain barrier model |
| Post doctoral fellow | Daniel Paape | N-myristoyl transferase as a drug target for visceral and cutaneous leishmaniasis |
| Post doctoral fellow | Giles Velarde (50%, based at Sanger Institute) |
Kinetoplastid Bioinformatics |
| Post doctoral fellow | Matthew Rogers (based at Sanger Institute) |
Kinetoplastid Bioinformatics |
| Research Assistant | Barbara Smith |
Molecular biology; parasite transgenesis |
| Research Assistant | Michael Hodgkinson |
Protein expression and purification; parasite proteomics |
| Research student | Johannes Doehl |
Functional analysis of stage-regulated proteins in Leishmania Viannia
species |